---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-016950"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:53:42.121816+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed approves new cash bonus plan and equity policies for 2025

## Summary
- CEO Hochman and President Sherman eligible for 80% base salary cash bonus; CFO Taylor eligible for 50%.
- 2025 goals include BACKBEAT enrollment, Virtue Sirolimus program milestones, pipeline/partnerships, financial objectives.
- Stretch goals can boost bonus up to 60%; CFO bonus further adjustable up to 45% or zero on individual performance.
- VP+ officers may elect equity as 100% options, 100% RSUs, or 50/50; RSUs vest over 3 years starting at 24 months.
- Section 16 officers' RSU tax liabilities satisfied by share withholding, not market sales.

## SEC filing metadata
- accession: 0001104659-25-016950
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465925016950/0001104659-25-016950-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465925016950/tm257515d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-016950
- JSON: https://secwatch.observer/filing/0001104659-25-016950.json
- Plain text: https://secwatch.observer/filing/0001104659-25-016950.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.